Stay updated with breaking news from Cypath Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March ...
BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately.
31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...
BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment.
10.11.2022 - bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced Sheila Habib, MD, Director of Pulmonary Lung Nodule Clinic and the Lung Cancer Screening Program at the South Texas Veterans Health Care Systems’ Audie L. Murphy Memorial Veterans ... Seite 1